MNGI Digestive Health, P.A.
Maplewood, Minnesota, United States
Gastroenterologist in Maplewood, Minnesota
1997 Sloan Pl, Maplewood, MN 55117
About MNGI Digestive Health, P.A.
"MNGI Digestive Health (previously Minnesota Gastroenterology) specializes in the diagnosis and treatment of adults and children with GI disorders. Our board-certified gastroenterologists have expertise in virtually all types of digestive conditions, such as acid reflux disease, heartburn and swallowing disorders, Crohn's disease and ulcerative colitis, hepatitis and liver disease, biologics and infusion therapy, celiac disease, hemorrhoid banding and more."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
CymaBay Therapeutics, Inc.
2
Gilead Sciences
2
Clinical Trials at MNGI Digestive Health, P.A.
During the past decade, MNGI Digestive Health, P.A. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
2017-12-12
2025-12-01
Recruiting
500
Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis
2019-03-27
2022-12-23
Terminated
419
Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis
2019-10-17
2021-09-02
Completed
11
RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)
2021-04-21
2023-08-01
Active, not recruiting
193
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MNGI Digestive Health, P.A.
According to Clinical.Site data, the most researched conditions in "MNGI Digestive Health, P.A." are
"Primary Sclerosing Cholangitis" (2 trials), "Compensated Cirrhosis" (1 trials), "Primary Biliary Cholangitis" (1 trials) and "Primary Biliary Cirrhosis" (1 trials). Many other conditions were trialed in "MNGI Digestive Health, P.A." in a lesser frequency.
Clinical Trials Intervention Types at MNGI Digestive Health, P.A.
Most popular intervention types in "MNGI Digestive Health, P.A." are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "CILO" (1 trials), "Cilofexor" (1 trials), "Seladelpar 10 mg" (1 trials) and "Seladelpar 10 mg Capsule" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MNGI Digestive Health, P.A.
The vast majority of trials in "MNGI Digestive Health, P.A." are
4 trials for "All" genders.
Clinical Trials Status at MNGI Digestive Health, P.A.
Currently, there are NaN active trials in "MNGI Digestive Health, P.A.".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in MNGI Digestive Health, P.A.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in MNGI Digestive Health, P.A., 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".